Description

Edarbi (azilsartan medoxomil) tablets 40 mg. №28

Ingredients:

Each tablet contains 40 mg of azilsartan medoxomil.

Dosage:

The recommended dosage is one 40 mg tablet once daily.

Indications:

Edarbi is indicated for the treatment of hypertension in adults.

Contraindications:

Do not use Edarbi if you are pregnant, have severe renal impairment, or are allergic to azilsartan medoxomil.

Directions:

Take Edarbi exactly as prescribed by your healthcare provider. It can be taken with or without food.

Scientific Evidence:

A study published in the American Journal of Hypertension demonstrated the efficacy of azilsartan medoxomil in reducing blood pressure in patients with hypertension. The study showed a significant decrease in both systolic and diastolic blood pressure compared to a placebo group.

Additional Information:

Edarbi works by blocking the action of angiotensin II, a hormone that constricts blood vessels, leading to decreased blood pressure. This medication is well-tolerated and has a low risk of side effects compared to other similar drugs in its class.

Clinical trials have shown that Edarbi is effective not only as a standalone treatment but also in combination with other antihypertensive medications. It provides consistent and reliable blood pressure control, reducing the risk of cardiovascular events associated with hypertension.